Primary: participant‐rated good/excellent control of symptoms Not measured · people with moderate to severe nickel sulphate‐induced allergic contact dermatitis based on clinical history (hand eczema) and proven by…
The review found no eligible studies for this question.
1 finding from 1 review
Primary: adverse events ‐ burning/itching at application site · people with moderate to severe nickel sulphate‐induced allergic contact dermatitis based on clinical history (hand eczema) and proven by…
Topical calcineurin inhibitors: tacrolimus 0.1% ointment showed no clear difference in primary: adverse events ‐ burning/itching at application site compared with vehicle (moderate certainty).
1 finding from 1 review
Secondary: investigator‐rated reduction in severity ‐ Not measured · people with moderate to severe nickel sulphate‐induced allergic contact dermatitis based on clinical history (hand eczema) and proven by…
The review found no eligible studies for this question.
1 finding from 1 review
Total clearance (at 4 weeks or less) Investigator's assessment · patients with seborrhoeic dermatitis
Strong steroid (class III or IV) showed no clear difference in total clearance (at 4 weeks or less) Investigator's assessment compared with mild steroid (class I or II) (moderate certainty).
1 finding from 1 review
Total clearance (more than 4 weeks) Investigator's assessment · patients with seborrhoeic dermatitis
Strong steroid (class III or IV) may leads to lower total clearance (more than 4 weeks) Investigator's assessment compared with mild steroid (class I or II) (low certainty).
1 finding from 1 review
Intervention not reported
Mean change from baseline in number of topical or systemic steroids at 6 months*2 · Participants with a diagnosis of JIA and uveitis who are aged 2 to 18 years old
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Total amount of topical corticosteroids used · people with eczema
1 finding from 1 review
Total amount of topical corticosteroids used · people with eczema
1 finding from 1 review
Pain intensity (0‐10cm visual analogue scale) · Adults with lateral elbow pain
1 finding from 1 review
Treatment success Fair, good or excellent effectiveness · Adults with lateral elbow pain
Topical NSAIDs may leads to higher treatment success Fair, good or excellent effectiveness compared with placebo (low certainty).
1 finding from 1 review
Function/disability · Adults with lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · Adults with lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · Adults with lateral elbow pain
1 finding from 1 review
Adverse events · Adults with lateral elbow pain
Topical NSAIDs showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Hearing loss · Children with otitis media with effusion
Summary of findings: oral steroids showed no clear difference in hearing loss [6 weeks] compared with control (moderate certainty).
1 finding from 1 review
OME resolution at short‐term · Children with otitis media with effusion
Summary of findings: oral steroids showed no clear difference in OME resolution at short‐term compared with control (moderate certainty).
1 finding from 1 review
OME resolution at intermediate‐term · Children with otitis media with effusion
Summary of findings: oral steroids showed no clear difference in OME resolution at intermediate‐term compared with control (moderate certainty).
1 finding from 1 review
OME resolution at long‐term · Children with otitis media with effusion
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptoms · Children with otitis media with effusion
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects [4 to 6 weeks] · Children with otitis media with effusion
1 finding from 1 review